Академический Документы
Профессиональный Документы
Культура Документы
sigma-aldrich.com/analytical
Introduction
1.
2.
3.
4.
Aim
Understand retention mechanisms involved in HILIC the basis for method
development practices
Provide concepts and models for retention
Provide some method development hints/pitfalls to watch for
Illustrate with a few examples
Si-OH
Homogeneous binary
mobile phase high in
organic content
Si-OH
Si-OH
Si-OH
Si-OH
Si-OH
Si-OH
Si-OH
Si-OH
Si-OH
Si-OH
Si-OH
Si-OH
Biphasic system
aqueous-rich solvent
Si-OH
aqueous-depleted solvent
HILIC conditions
initial conditions
Si-OSi-OH
Si-OSi-OH
Si-O-
aqueous-rich solvent
Biphasic system
Si-OH
CH3
aqueous-depleted solvent
HILIC conditions
OH
NH2
HO
Normetanephrine
CH3
HN
10
Retention (min)
HO
OH
Synephrine
10
20
30
40
50
60
70
80
90
100
% Acetonitrile
Retention (min)
0
0
10
20
30
40
50
% Acetonitrile
60
70
80
90
100
So What?
The previous example shows that there may be very different mechanisms
causing retention and selectivity in HILIC systems:
Bare silica phase exhibits partition (not impacted by buffer concentration)
PFP phase exhibits IEX (highly impacted by buffer concentration)
Differing retention mechanisms give rise to alternative selectivity and
retention same as in reversed-phase
So What, What?
A fundamental understanding of underlying retention mechanisms is vital
for:
Choosing the right set of initial conditions for a given separation problem (column
chemistry, mobile phase additives, aqueous/organic ratios)
Knowing the correct knobs to turn to facilitate method development and
optimization
Placing the needed controls on the system to establish a rugged and robust
method
R1
R2
Si
R1
F
F
F5
HO
HO
HO
OH
R2
R3
R1
Si
OH
R2
OH5
2013 Sigma-Aldrich Co. All rights reserved.
10
Selected Probes
Structure
H3C
H3C
pKa(MB)
LogD(8.0)
LogP
MW
name
9.38
-0.37
1.08
165.23
pseudoephedrine
9.38
-0.37
1.08
165.23
ephedrine
9.37
-1.35
0.13
167.21
synephrine
NH
OH
H3C
H3C
ACD/Labs, PhysChemProp, v. 12
NH
OH
CH3
HN
HO
OH
11
12
1.00
y = -0.6525x + 1.2104
R2 = 0.9984
log k'
0.80
0.60
y = -0.8187x + 1.1259
R2 = 1
0.40
0.20
0.00
0.00
y = -0.2199x + 0.2455
R2 = 0.9934
0.20
0.40
0.60
0.80
1.00
1.20
OH5
HILIC
F5
Linear (HILIC)
Linear (F5)
Linear (OH5)
13
Discussion
Examining observed retention in the present study:
Keys
All three analytes have very similar pKa values and thus should, excluding any
outside interference, IEX the same
Synephrine is more polar than the ephedrine pair
The ephedrine pair are identical in physical properties except for their
orientation in space
OH5
Little IEX behavior (lack of surface interactions)
Synephrine elutes after the ephedrine pair (partitioning)
Conclusion close to pure HILIC partitioning
14
Discussion (continued)
HILIC (bare silica phase)
Mid range IEX behavior (surface interactions)
Synephrine elutes after the ephedrine pair (partitioning)
Greater overall retention (relative to the two other phases) mechanistic synergy
Conclusion: synergistic combination of partitioning and ion-exchange
PFP (F5)
Near total IEX behavior (surface interactions at least long range)
Synephrine elutes prior to ephedrine pair (lack of HILIC partitioning)
Conclusion: Mainly Ion-exchange
15
R2
OH5
F5
HO
HO
OH
HO
F
F
Aqueous
Layer
OH
R1
Si
R3
R2
Aqueous Layer
-
R1 Si
R2
R1
16
Stationary Phase
Interactions
Partitioning
Polar
Ionic
Bare Silica
moderate
moderate
Zwitterionic
strong
weak
Amide
strong
weak
Diol/Polyol
strong
weak
PFP
weak
strong
Cyano
weak
strong
17
For example if we have a sample with polar neutral molecules, we know we will
need partition as they will not interact ionically F5 would be a bad choice, OH5
and bare silica would provide more promise
18
19
NH
CH3
NH
CH3
CH3
CH3
CH3
Butylone
MDPV
O
NH
CH3
methylone
O
NH
CH3
O
20
CH3
H3C
ethylone
NH
CH3
CH3
4-fluoromethcathinone
H3C
mephedrone
Monoisotopic Mass = 177.115364 Da
CH3
methedrone
Monoisotopic Mass = 193.110279 Da
O
O
CH3
CH3
NH
NH
CH3
CH3
3-fluoromethcathinone
CH3
CH3
Buphedrone
20
A1849_029_B031
1: Scan ES+
194
3.01e8
6.01
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
178
3.04e8
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
208
2.82e8
7.00
8.00
9.00
10.00
1: Scan ES+
276
2.04e8
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
222
3.64e8
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
TIC
1.05e9
7.00
8.00
9.00
5.76
A1849_029_B031
1.00
2.00
3.00
4.00
5.00
4.92
A1849_029_B031
1.00
2.00
3.00
4.00
5.00
6.00
6.76
A1849_029_B031
1.00
2.00
3.00
4.00
3.88
5.00
4.95
A1849_029_B031
0
A1849_029_B031
1.00
2.00
3.00
4.00
3.87
5.00
4.94
5.78 6.01
1.30
1.00
2.00
3.00
4.00
5.00
6.00
6.76
Time
10.00
21
A1849_029_B015
1: Scan ES+
194
2.97e8
7.01
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
178
3.47e8
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
208
3.08e8
5.74
A1849_029_B015
1.00
2.00
3.00
4.00
5.00
6.19
A1849_029_B015
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
276
3.32e8
5.00
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
222
3.91e8
6.00
7.00
8.00
9.00
10.00
1: Scan ES+
TIC
8.22e8
8.00
9.00
3.82
A1849_029_B015
1.00
2.00
3.00
4.00
4.11
4.80
A1849_029_B015
0
A1849_029_B015
1.00
2.00
3.00
4.00
3.82
4.11
5.00
4.80
5.74
6.18
7.01
1.27 1.59
1.00
2.00
3.00
4.00
5.00
6.00
7.00
Time
10.00
22
1.0
2.0
3.0
System:
4.0
Time (min)
5.0
6.0
rt
MDPV
2.0
Buphedrone
2.2
3-fluoromethcathinone
2.7
butylone
2.9
ethylone
3.4
3-fluoromethcathinone
3.7
mephedrone
4.6
methylone
5.2
methedrone
6.0
7.0
Column:
Mobile Phase:
Flow:
0.6mL/min
Temperature:
35 C
System Pressure:
127bar
Injection Vol:
1uL
MS Detection:
ESI+, 100-1000m/z ,
Sample:
23
OH
O
N
HN
N
N
O
O
HO
HO
HO
OH
OH
OH
HO
Uridine
Cytidine
Inosine
O
N
HN
H2N
HO
HO
CH3
HN
N
HO
HO
CH3
N
N
NH2
HO
HO
Guanosine
OH
HO
OH
Ribothymidine
5-Methyluridine
HO
OH
5-Methylcytidine
2013 Sigma-Aldrich Co. All rights reserved.
24
Structures
NH2
NH2
NH
H3C
N
N
N
S
HO
HO
HO
HO
HO
OH
HO
2-Thiocytidine
2'-O-Methylcytidine
NH
CH3
CH3
HN
N
HN
H2N
H3C
1-Methyladenosine
NH
7-Methylguanosine
OH
HO
HO
OH
HO
HO
H3C
OH
HO
OH
Pseudouridine
HO
OH
3-Methylcytidine metosulfate
25
5 mM ammonium formate, pH 3
5 mM ammonium formate, pH 4
5 mM ammonium acetate, pH 5
26
5 mM ammonium formate, pH 3
5 mM ammonium formate, pH 4
5 mM ammonium acetate, pH 5
27
Ascentis Express F5
5 mM ammonium acetate, pH 6.9 unadjusted
5 mM ammonium formate, pH 3
5 mM ammonium formate, pH 4
5 mM ammonium acetate, pH 5
28
12 NUCLEOSIDES_ASCEXPOH5.CDF
55
50
45
8.6
6.5
9.02
30
25
11.11
15
6.08
5.28
4.62
20
10.29
3.07
Response
35
7.79
2.75
40
2.91
10
5
0
0
6
7
Retention Time (min)
10
11
12
13
29
N
N
H
N
H
H
CH3
H
O
H3C
H3C
O
Yohimbine
OH
Ajmalicine
4
5
6
Retention Time (min)
1. Ajmalicine
2. Yohimbine
10
Conditions:
Column: Ascentis Express F5, 10 cm x 3.0 mm, 2.7 m (53766-U)
Mobile Phase: 2 mM ammonium acetate in 90% acetonitrile, pH adjusted
to 6.0 with acetic acid (post addition of organic)
Flow Rate: 0.5 mL/min
Temperature : 35C
Detection: UV. 275 nm
Injection: 2 L
2013 Sigma-Aldrich Co. All rights reserved.
1. Yohimbine
4
5
6
Retention Time (min)
10
Conditions:
Column: Ascentis Express F5, 10 cm x 3.0 mm, 2.7 m (53766-U)
Mobile Phase: 2 mM ammonium acetate in 90% acetonitrile, pH adjusted
to 6.0 with acetic acid (post addition of organic)
Flow Rate: 0.5 mL/min
Temperature : 35C
Detection: UV. 275 nm
Injection: 2 L
2013 Sigma-Aldrich Co. All rights reserved.
4
5
6
Retention Time (min)
10
4
5
6
Retention Time (min)
Conditions:
Column: Ascentis Express HILIC, 10 cm x 3.0 mm, 2.7 m (53970-U)
Mobile Phase: 2 mM ammonium acetate in 90% acetonitrile, pH adjusted
to 6.0 with acetic acid (post addition of organic)
Flow Rate: 0.5 mL/min
Temperature : 35C
Detection: UV. 275 nm
Injection: 2 L
2013 Sigma-Aldrich Co. All rights reserved.
10
H3C
NH
OH
H3C
ephedrine
H3C
H3C
CH3
NH2
N
OH
H3C
H3C
OH
norephedrine
methylephedrine
CH3
NH
OH
OH
HN
NH2
HO
CH3
pseudoephedrine
norpseudoephedrine
OH
synephrine
Bell, D. S., H. M. Cramer, et al. (2005). "Rational method development strategies on a fluorinated liquid chromatography stationary phase: Mobile
phase ion concentration and temperature effects on the separation of ephedrine alkaloids." Journal of Chromatography A 1095(1-2): 113-118.
34
1.000
log k
0.800
0.600
norephedrine
synephrine
methylephedrine
ephedrine
pseudoephedrine
4 mM optimum
0.400
0.200
0.000
2
10
35
Experimental
Retention data was first acquired at 2 mM and 10 mM ammonium acetate in 90%
acetonitrile
Acquisitions were performed on a Shimadzu 10A VP HPLC system
Column:
Mobile Phase:
Flow Rate:
Temp.:
Det.:
Inj.:
Sample:
36
ESI+ 152
8
10
Time (min)
12
8
10
Time (min)
12
14
16
18
14
16
18
ESI+ 168
8
10
Time (min)
12
8
10
Time (min)
12
14
16
18
ESI+ 166
norephedrine
norpseudoephedrine
synephrine
methylephedrine
ephedrine
pseudoephedrine
ESI+ 180
1.
2.
3.
4.
5.
6.
14
16
Understanding
dominant
interactions greatly
facilitates method
development
18
37
38
HILIC is generally restricted to highly polar and/or ionic analytes. Low octanolwater coefficients (Log P generally less than 1) and ionizable bases are
considered good candidates for this mode of chromatography.
Make sure samples are prepared in weak HILIC solvents (high organic, low salt
concentrations)
A good general starting mobile phase for HILIC is 2-10 mM ammonium acetate
or formate in 90% acetonitrile leaving pH unadjusted (~pH7 where both strong
bases and surface silanols are ionized)
If the analytes are nonionic or IEX is not desirable, a starting point could be 10
mM ammonium formate, pH 3.0, in 90-95% acetonitrile.
Choice of formate or acetate buffer informed primarily by volatility and MS
compatibility, and solubility at high levels of organic
Run isocratically if possible, if gradients are necessary, change one variable only
(ie organic or buffer, not both)
39
40
pH adjustment
Be aware that pH can modify the ionization of both the analyte and the
chromatographic surface
Modern surface silanols exhibit a range of pKa values finding the right pH
is often a balance between analyte and surface degrees of ionization
Buffer concentrations need to be as exact as possible
Best to measure and state the pH after the addition of organic
41
s
pH
w
10
9
8
7
6
5
4
3
2
2
10
12
w
pH
w
2013 Sigma-Aldrich Co. All rights reserved.
42
s
w
pKa
Correlation
(R2)
25
9.32
0.9997
50
9.02
0.9996
75
90
8.88
8.34
Analyte
Literature pKa
pKa
Correlation
(R2)
Amitriptyline
9.4
8.34
0.9923
Nortriptyline
9.7
8.92
0.9920
Diphenhydramine
9.0
8.33
0.9978
Verapamil
8.9
7.98
0.9976
Alprenolol
9.7
8.73
0.9855
s
w
0.9956
0.9923
43
The degree of analyte ionization would be only about 10% and thus much less apt
to interact via ion-exchange
It is thus extremely important to take the variation of both pH and pKa into account
when developing methods
44
IEX dominated
Partition dominated
OH5 phase/Amide
Zwiterionic
45
Summary
Developed some models to describe what is happening in HILIC
Take home message: if you have basic analytes in your system, expect IEX
mechanisms to be prevalent
Employing and controlling IEX is different than partitioning need to be prepared
to do both
Showed that different phases offer different degrees of partition and IEX
OH5/Amide/Zwitterionic mainly partition
Bare Silica partition and IEX
F5/Cyano IEX
Demonstrated through application how one can choose and omit column
chemistries based on analyte knowledge
46
Acknowledgements
Hillel Brandes
Xiaoning Lu
Hugh Cramer
Craig Aurand
Errol Fernandes
Carmen Santasania
Gaurang Parmar
Wayne Way
Separation Science
Q&A
2.7 m
9 Phases
5 m
7 Phases
48